📰 Exact Sciences News
Page 58 - Exact Sciences News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Exact Sciences. Real-time updates on events, politics, business and more.
April 21, 2023
Kestra Private Wealth Services LLC purchased a new position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund purchased 4,920 shares of the medical research company’s stock, valued at approximately $244,000. Other institutional investors […]
April 21, 2023
DekaBank Deutsche Girozentrale lowered its position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 8.1% during the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 44,556 shares of the medical research company’s stock after selling 3,909 shares during the quarter. DekaBank Deutsche […]
April 21, 2023
Should You Buy or Sell Exact Sciences Stock? Get The Latest EXAS Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
April 20, 2023
Her flagship Ark Innovation ETF has slid 37% during the past year, but has rebounded 21% so far this year. Cathie Wood, chief executive of Ark Investment…
April 20, 2023
The CEO Roundtable on Cancer was among several organizations represented at the meeting convened by the National Minority Quality Forum.
April 19, 2023
Woods flagship Ark Innovation ETF has lost 33% over the past year, but has rebounded 23% so far this year.
April 19, 2023
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) shares were up 4.3% during mid-day trading on Wednesday . The company traded as high as $68.45 and last traded at $68.24. Approximately 1,059,655 shares were traded during mid-day trading, a decline of 55% from the average daily volume of 2,356,972 shares. The stock had previously closed at […]
April 18, 2023
Resources Investment Advisors LLC. lifted its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 1.0% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 100,193 shares of the medical research company’s stock after purchasing an additional 1,023 shares […]
April 18, 2023
The original writing was hidden in part by a 19th century attempt to read it.
April 17, 2023
Empire Life Investments Inc. cut its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 1.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 157,000 shares of the medical research company’s stock after selling 1,728 shares during the period. Empire Life Investments Inc.’s holdings in Exact Sciences were worth $7,773,000 at the […]